These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 1899311

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-T cell-specific immunoconjugates in mice: in vivo effects.
    Mottram PL, Smyth M, Pietersz GA, Clunie GJ, McKenzie IF.
    Transplant Proc; 1989 Oct; 21(5):3757-8. PubMed ID: 2573184
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunosuppression by aminopterin or idarubicin conjugated to anti-CD8 in the mouse heart allograft model.
    Mottram PL, Pietersz GA, Purcell LJ, Krauer K, McKenzie IF.
    Transplant Proc; 1992 Oct; 24(5):2301. PubMed ID: 1413068
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
    Hamano K, Morris PJ, Wood KJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
    [No Abstract] [Full Text] [Related]

  • 8. Distribution of Ly-6C on lymphocyte subsets: I. Influence of allotype on T lymphocyte expression.
    Schlueter AJ, Malek TR, Hostetler CN, Smith PA, deVries P, Waldschmidt TJ.
    J Immunol; 1997 May 01; 158(9):4211-22. PubMed ID: 9126982
    [Abstract] [Full Text] [Related]

  • 9. Generation and regeneration of a novel anti-CD8-resistant cytolytic T lymphocyte population.
    Dougall DS, Lamousé-Smith ES, McCarthy SA.
    Cell Immunol; 2000 Oct 10; 205(1):1-12. PubMed ID: 11078602
    [Abstract] [Full Text] [Related]

  • 10. Effects of anti-L3T4 and anti-LYT2 monoclonal antibody therapy on cardiac allograft survival in presensitized recipients.
    Madsen JC, Wood KJ, Morris PJ.
    Transplant Proc; 1989 Feb 10; 21(1 Pt 1):1022. PubMed ID: 2495588
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-CD4 IgG2a monoclonal antibody treatment prevents the expansion of T cells in the spleen during murine graft-vs-host disease.
    Noort WA, Benner R, Savelkoul HF.
    Transplant Proc; 1995 Feb 10; 27(1):384-6. PubMed ID: 7879030
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of murine lupus with monoclonal antibody to L3T4. II. Effects on immunohistopathology of thymus, spleen, and lymph node.
    Ermak TH, Steger HJ, Wofsy D.
    Lab Invest; 1989 Oct 10; 61(4):447-56. PubMed ID: 2529396
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunosuppression of graft rejection with idarubicin-monoclonal antibody conjugates by elimination of T cell subsets in vivo.
    Smyth MJ, Pietersz GA, McKenzie IF.
    Transplantation; 1988 Jul 10; 46(1):126-31. PubMed ID: 2899362
    [Abstract] [Full Text] [Related]

  • 20. Effect of L3T4 and Lyt-2 monoclonal antibodies on islet xenograft (rat to mouse) rejection.
    Kawai M, Gotoh M, Monden M, Yamamoto H, Ichikawa T, Valdivia LA, Mori T, Uenaka A, Nakayama E.
    Transplant Proc; 1989 Feb 10; 21(1 Pt 3):2709-10. PubMed ID: 2495677
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.